Rosiglitazone Effect on Mitochondria and Lipoatrophy

NCT00367744 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Rosiglitazone
DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]